BRK-B vs NNY
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
NNY exhibits a weak deterministic health profile with a Piotroski F-Score of 3/9, indicating poor fundamental momentum. However, as a municipal value fund, its valuation is best viewed through its Price-to-Book ratio of 1.00, suggesting it is trading exactly at its net asset value. While profitability metrics are negative and technical trends are bearish (0/100), the fund maintains a stable dividend yield of 4.14% and positive long-term price appreciation. The overall outlook is neutral, as the fund serves as an income vehicle rather than a growth equity.
Compare Another Pair
Related Comparisons
BRK-B vs NNY: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Nuveen New York Municipal Value Fund (NNY) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.